Active immuno-oncological agents in development U.S. 2019, by type
During 2019, there were a total of 1,837 active pipeline immuno-oncological agents in development in the United States. Of these, 507 were cell therapy drugs and 464 were other immunomodulator agents. This statistic shows the active immuno-oncological agents in drug development pipeline in the U.S. in 2019, by therapy type.